Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 162   

Articles published

NVS 77.10 -3.57 (-4.43%)
price chart
How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?
A fresh analysis of Novartis AG (ADR) (NYSE:NVS) drug Entresto has shown that it can significantly reduce heart failure deaths.
Novartis AG (ADR) (NYSE:NVS) Biosimilars Roadmap
Novartis AG (ADR) (NYSE:NVS) is in the process of tripling its portfolio of biosimilar drugs by 2020. The company is particularly working to develop alternatives to blockbuster drugs such as Johnson & Johnson (NYSE:JNJ) Remicade and Amgen, Inc.
How Many Novartis AG (ADR) (NYSE:NVS)'s Analysts Are Bearish?  Franklin Independent
Novartis AG (ADR) Has Enough Arsenal to Steer Clear of Ongoing Rout  Bidness ETC
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Novartis AG (ADR) Stock Price Gaps Up Today; Buyers Are Thriving
The stock of Novartis AG (ADR) (NYSE:NVS) gapped up by $0.6 today and has $109.07 target or 40.00% above today's $77.91 share price.
What Next for Novartis AG (ADR) After Today's Gap Down?
The stock of Novartis AG (ADR) (NYSE:NVS) gapped down by $0.45 today and has $72.47 target or 6.00% below today's $77.10 share price.
Novartis AG (ADR) Aiming to Target Biosimilar Market by 2020
By 2020, Novartis AG (NYSE:NVS) plans to launch a number of biosimilar versions of the blockbuster drugs in order to enter multiple therapeutic markets.
Novartis AG (ADR) (NYSE:NVS) Sells 14 Drug Brands Worth $293 Million To Sun In ...
Novartis AG (ADR) (NYSE:NVS) has sold more than a dozen drugs to India's Sun Pharmaceutical in Japan. The development follows a trend that has become popular among major pharmaceutical companies.
Novartis Is Under SEC Investigation, Probes Reporter Says  Benzinga
How high can Novartis AG (NVS) stock go? Analysts hold $94.5 price target  CWRU Observer
Novartis AG (ADR) First-Quarter Earnings: What to Expect?
Novartis AG (ADR) (NYSE:NVS) is set to announce its financial results for the first quarter of 2016 (1Q) on Thursday, April 21.
Healthcare Stocks on Analysts Radar: ImmunoGen, Inc. (NASDAQ:IMGN), Novartis ...
Shares of Novartis AG (ADR) (NYSE:NVS) slipped -0.96% to $79.34 at 12:13 PM EDT. The stock exchanged hands of 885,045 shares recently versus average trading capacity of 2.23 million shares.
HC Stocks Vigilant: CIGNA Corporation (NYSE:CI), Novartis AG (ADR) (NYSE:NVS)
Shares of Novartis AG (ADR) (NYSE:NVS) ended Tuesday session in green amid volatile trading. The shares closed up +0.79 points or 1.00% at $79.46 with 2.43 million shares getting traded.